未登录Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the α-emitting radionuclides 212Bi or 211At
Wesley, JN; McGee, EC; Garmestani, K; Brechbiel, MW; Yordanov, AT; Wu, C; Gansow, OA; Eckelman, WC; Bacher, JD; Flynn, M; Goldman, CK; MacLin, M; Schwartz, UP; Jackson-White, T; Phillip, CM; Decker, J; Waldmann, TA
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Preparation and in vivo evaluation of linkers for 211At labeling of humanized anti-Tac
Yordanov, AT; Garmestani, K; Zhang, M; Zhang, Z; Yao, Z; Phillips, KE; Herring, B; Horak, E; Beitzel, MP; Schwarz, UP; Gansow, OA; Plascjak, PS; Eckelman, WC; Waldmann, TA; Brechbiel, MW
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Preparation of the novel chelating agent N-(2-aminoethyl)-trans-1,2-diaminocyclohexane-N,N',N''-pentaacetic acid (H(5)CyDTPA), a preorganized analogue of diethylenetriaminepentaacetic acid (H(5)DTPA), and the structures of Bi-III(CyDTPA)(2-) and Bi-III(H(2)DTPA) complexes
Brechbiel, MW; Gansow, OA; Pippin, CG; Rogers, RD; Planalp, RP
分享
收藏
分享
收藏